Patients harboring the ELANE mutation may experience the onset of myelodysplastic syndrome (MDS), AML, or, in rarer cases, acute lymphoblastic leukemia (ALL) [26]. This evidence concerns the gene ELANE and acute lymphoblastic leukemia.